Inovus Ltd

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Inovus Ltd - overview

Established

2012

Location

-, -, UK

Primary Industry

Medical Devices & Equipment

About

Inovus Ltd is a UK-based company specializing in the development of innovative medical technology solutions, focusing on advanced surgical training platforms that enhance educational experiences for healthcare professionals. Founded in 2012 in the UK, Inovus Ltd develops simulation-based training systems for surgical professionals. The company was founded by Jordan Van Flute and has undergone no significant business pivots. Inovus has raised a total of GBP 500,000, with the latest funding round occurring on November 14, 2018, from Mercia Asset Management.


This funding round valued Inovus at GBP 3. 72 million post-money. Inovus specializes in creating advanced surgical training platforms that offer simulation-based systems designed for healthcare professionals. These training systems provide realistic environments to replicate surgical scenarios, improving skill acquisition among trainees.


Their products are marketed globally, targeting medical institutions, surgical training centers, and universities to enhance surgical outcomes through comprehensive training tools. Inovus generates revenue through direct sales to healthcare institutions and collaborations with medical training organizations. Their sales model includes both outright purchases and subscription options for ongoing access to updated training resources. The pricing structure is flexible, accommodating various institutional sizes and needs, while also establishing recurring revenue through service contracts and training updates.


Inovus aims to leverage recent funding of GBP 500,000 raised in November 2018 to expand its product line, focusing on new simulation technologies set to be launched in 2023. The company plans to enter new markets in North America and Asia by 2024, targeting healthcare institutions that require innovative training solutions. The funding will support product development and market entry strategies.


Current Investors

Mercia Asset Management

Primary Industry

Medical Devices & Equipment

Sub Industries

Medical Devices & Equipment

Website

www.inovus.org

Company Stage

Early Stage

Total Amount Raised

Subscriber access only

Inovus Ltd - financials

Fiscal Year EndedJan 31, 2019
Revenue (USD)-
% Revenue Growth (YoY)-
EBITDA (USD)-
Operating Income (USD)-
Operating Margin-
% EBITDA Margin-
NET Income (USD)-
% Net Margin-

Inovus Ltd - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.